Meningioma and peritumoral edema segmentation of preoperative MRI brain scans

Artificial intelligence for brain diseases: A systematic review

Artificial intelligence (AI) is a major branch of computer science that is fruitfully used for analyzing complex medical data and extracting meaningful relationships in datasets, for several clinical aims. Specifically, in the brain care domain, several innovative approaches have achieved remarkable results and open new perspectives in terms of diagnosis, planning, and outcome prediction. In this work, we present an overview of different artificial intelligent techniques used in the brain care domain, along with a review of important clinical applications. A systematic and careful literature search in major databases such as Pubmed, Scopus, and Web of Science was carried out using "artificial intelligence" and "brain" as main keywords. Further references were integrated by cross-referencing from key articles. 155 studies out of 2696 were identified, which actually made use of AI algorithms for different purposes (diagnosis, surgical treatment, intra-operative assistance, and postoperative assessment). Artificial neural networks have risen to prominent positions among the most widely used analytical tools. Classic machine learning approaches such as support vector machine and random forest are still widely used. Task-specific algorithms are designed for solving specific problems. Brain images are one of the most used data types. AI has the possibility to improve clinicians' decision-making ability in neuroscience applications. However, major issues still need to be addressed for a better practical use of AI in the brain. To this aim, it is important to both gather comprehensive data and build explainable AI algorithms.

Investigating the Behaviour of Machine Learning Techniques to Segment Brain Metastases in Radiation Therapy Planning

This work aimed to investigate whether automated classifiers belonging to feature-based and deep learning may approach brain metastases segmentation successfully. Support Vector Machine and V-Net Convolutional Neural Network are selected as representatives of the two approaches. In the experiments, we consider several configurations of the two methods to segment brain metastases on contrast-enhanced T1-weighted magnetic resonance images. Performances were evaluated and compared under critical conditions imposed by the clinical radiotherapy domain, using in-house dataset and public dataset created for the Multimodal Brain Tumour Image Segmentation (BraTS) challenge. Our results showed that the feature-based and the deep network approaches are promising for the segmentation of Magnetic Resonance Imaging (MRI) brain metastases achieving both an acceptable level of performance. Experimental results also highlight different behaviour between the two methods. Support vector machine (SVM) improves performance with a smaller training set, but it is unable to manage a high level of heterogeneity in the data and requires post-processing refinement stages. The V-Net model shows good performances when trained on multiple heterogeneous cases but requires data augmentations and transfer learning procedures to optimise its behaviour. The paper illustrates a software package implementing an integrated set of procedures for active support in segmenting brain metastases within the radiotherapy workflow.